167 related articles for article (PubMed ID: 35336001)
1. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles.
Ibarra LE; Camorani S; Agnello L; Pedone E; Pirone L; Chesta CA; Palacios RE; Fedele M; Cerchia L
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336001
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Short RNA Aptamers for TNBC Cell Targeting.
Camorani S; d'Argenio A; Agnello L; Nilo R; Zannetti A; Ibarra LE; Fedele M; Cerchia L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408872
[TBL] [Abstract][Full Text] [Related]
3. Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors.
Agnello L; Tortorella S; d'Argenio A; Carbone C; Camorani S; Locatelli E; Auletta L; Sorrentino D; Fedele M; Zannetti A; Franchini MC; Cerchia L
J Exp Clin Cancer Res; 2021 Jul; 40(1):239. PubMed ID: 34294133
[TBL] [Abstract][Full Text] [Related]
4. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies.
Camorani S; Caliendo A; Morrone E; Agnello L; Martini M; Cantile M; Cerrone M; Zannetti A; La Deda M; Fedele M; Ricciardi L; Cerchia L
J Exp Clin Cancer Res; 2024 Mar; 43(1):92. PubMed ID: 38532439
[TBL] [Abstract][Full Text] [Related]
5. Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles.
Jin G; He R; Liu Q; Dong Y; Lin M; Li W; Xu F
ACS Appl Mater Interfaces; 2018 Apr; 10(13):10634-10646. PubMed ID: 29323875
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status.
Caverzán MD; Beaugé L; Chesta CA; Palacios RE; Ibarra LE
J Photochem Photobiol B; 2020 Nov; 212():112045. PubMed ID: 33022469
[TBL] [Abstract][Full Text] [Related]
7. Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.
Chen Z; Zeng Z; Wan Q; Liu X; Qi J; Zu Y
Biomaterials; 2022 Jan; 280():121259. PubMed ID: 34801254
[TBL] [Abstract][Full Text] [Related]
8. Metallated porphyrin-doped conjugated polymer nanoparticles for efficient photodynamic therapy of brain and colorectal tumor cells.
Ibarra LE; Porcal GV; Macor LP; Ponzio RA; Spada RM; Lorente C; Chesta CA; Rivarola VA; Palacios RE
Nanomedicine (Lond); 2018 Mar; 13(6):605-624. PubMed ID: 29376764
[TBL] [Abstract][Full Text] [Related]
9. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells.
Camorani S; Tortorella S; Agnello L; Spanu C; d'Argenio A; Nilo R; Zannetti A; Locatelli E; Fedele M; Comes Franchini M; Cerchia L
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297659
[TBL] [Abstract][Full Text] [Related]
11. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
12. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
[TBL] [Abstract][Full Text] [Related]
13. Trojan horse monocyte-mediated delivery of conjugated polymer nanoparticles for improved photodynamic therapy of glioblastoma.
Ibarra LE; Beaugé L; Arias-Ramos N; Rivarola VA; Chesta CA; López-Larrubia P; Palacios RE
Nanomedicine (Lond); 2020 Jul; 15(17):1687-1707. PubMed ID: 32689873
[No Abstract] [Full Text] [Related]
14. Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment.
Zhang T; Liu H; Li L; Guo Z; Song J; Yang X; Wan G; Li R; Wang Y
Bioact Mater; 2021 Nov; 6(11):3865-3878. PubMed ID: 33937590
[TBL] [Abstract][Full Text] [Related]
15. Conjugated polymer nanoparticles and their nanohybrids as smart photoluminescent and photoresponsive material for biosensing, imaging, and theranostics.
Chen X; Hussain S; Abbas A; Hao Y; Malik AH; Tian X; Song H; Gao R
Mikrochim Acta; 2022 Feb; 189(3):83. PubMed ID: 35118576
[TBL] [Abstract][Full Text] [Related]
16. Biological Functionalization of Conjugated Polymer Nanoparticles for Targeted Imaging and Photodynamic Killing of Tumor Cells.
Feng L; Zhu J; Wang Z
ACS Appl Mater Interfaces; 2016 Aug; 8(30):19364-70. PubMed ID: 27406913
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
[TBL] [Abstract][Full Text] [Related]
18. Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c.
Wan Q; Zeng Z; Qi J; Zhao Y; Liu X; Chen Z; Zhou H; Zu Y
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326720
[TBL] [Abstract][Full Text] [Related]
19. ROS-Responsive and active targeted drug delivery based on conjugated polymer nanoparticles for synergistic chemo-/photodynamic therapy.
Zhang Z; Lu Z; Yuan Q; Zhang C; Tang Y
J Mater Chem B; 2021 Mar; 9(9):2240-2248. PubMed ID: 33596297
[TBL] [Abstract][Full Text] [Related]
20. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
